Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections - Wikidata - awgldk - TriplyDB

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections

http://www.wikidata.org/entity/Q24562428

about

Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Hypocholesterolemia in sepsis and critically ill or injured patients NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis Collagen-like proteins of pathogenic streptococci Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese Longitudinal Healthy Longevity Survey.TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes Circulating lipoproteins are a crucial component of host defense against invasive Salmonella typhimurium infection.Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load.Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.Role of interleukin-18 in host defense against disseminated Candida albicans infection.Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group.Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice High cholesterol may protect against infections and atherosclerosis.Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics.A shed form of LDL receptor-related protein-1 regulates peripheral nerve injury and neuropathic pain in rodents.Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors.Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis.The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity.Serum Cholesterol Levels within the High Normal Range Are Associated with Better Cognitive Performance among Chinese Elderly.Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis.Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo.Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction.Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells.Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever.The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance.Classifying Aging As a Disease: The Role of Microbes.Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity.

P2860

Q24630340-2AE79F75-64EA-4B70-BD2D-8C28591AD4C9 Q24802517-8C0C5AF9-B51D-4BFE-9392-B28D623C31A7 Q24811631-955431BF-85CC-4D6F-99CC-4FE014C7811A Q29248479-8906E558-E30C-4F33-958C-69F2D13D9A72 Q30885171-F0ECFA5D-B2C6-4CB7-9545-753300F47E2B Q31037925-3BFB45E5-7C27-43ED-8A39-37EBF6112FF2 Q33401232-EDEEB5A7-22EF-4252-8A53-66BB08A78021 Q33877648-E13C8EBE-8997-4FF6-80DD-6C13494DF483 Q33935218-721F788C-BD55-4AD7-AA45-14DB68B3EE29 Q34122443-4BF6E4F1-FDF8-471F-B03B-00CC3A31A998 Q34230759-4B72360F-7B03-4DCE-8D7A-A4BF7C514434 Q34300368-9861B2E6-69BB-49D7-A509-C0F4EFB40486 Q34390416-A130949B-4365-466E-BBED-0C09FD5F1277 Q34619615-038084B2-6984-48E2-B5A4-BB483B81E788 Q34851532-3EC6B683-DC8A-4790-BB0B-E52B687D955A Q35176262-DAF365FD-67E5-4A60-8ADA-1B1BD9A873BC Q35435218-8AC7067B-9C09-46B9-9420-C106D3045E09 Q35550680-42BFC555-896F-4CE0-8DC6-AD02ADAA010B Q35590201-D3C02D8E-6365-43FC-B49C-38F26CDED341 Q35745943-7A1E16C8-D153-4D48-83A8-C354482915A2 Q36177405-F96033BA-D881-4923-A612-36F34E8BE960 Q36183578-06C63ECE-C238-471B-929D-109CADE1B4E5 Q36745042-502E31AB-E0B0-4C82-AC4B-16BAEEEC9648 Q36752468-6C61D5DD-BAB6-4EA6-94F2-3C23FB764353 Q36931760-10D0BDC0-DA1B-4A52-8C55-2866340A4E7D Q37113904-0A227CBA-A328-4978-8C3F-25167EBA9BB6 Q37465413-A5B53863-C2AF-4B49-AF76-940EE1017744 Q37612411-91FABFFA-A4D7-42B4-9019-ED21CFCF9381 Q37648984-0C91963E-B163-411B-BE56-45431E54A292 Q37862676-FD0EDF7C-C6BB-42B8-8C9F-DF46455475C5 Q39392957-8BCF9685-B53F-4CD9-B54A-7D3DA2B0CBA9 Q39537763-0F7F7A16-CB38-4832-B77F-16709A5B68A0 Q39570577-4C8F877E-13B1-4B9C-9742-A80303A9EADF Q39571335-6D88AFEF-A638-43CB-8459-36F692A6CED7 Q39723291-0ED646FA-BA57-41F5-87B2-E05246DDA6DB Q39906364-3D157919-2602-4FA6-93D6-B8FC2BDDF8F8 Q40586016-D117B585-56A6-4084-8840-D47534438DFE Q41064722-36934FF8-A9B7-48CD-A440-4739039F992F Q41855256-28A9EA92-505B-443E-9FA3-F0DD87C96BE3 Q41875028-0352B732-2242-4586-807A-8F3B720D0F2E

P2860

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections

http://www.wikidata.org/entity/Q24562428

description

1996 nî lūn-bûn

@nan

1996 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մարտին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Low-density lipoprotein recept ...... evere gram-negative infections

@ast

Low-density lipoprotein recept ...... evere gram-negative infections

@en

Low-density lipoprotein recept ...... evere gram-negative infections

@nl

type

label

Low-density lipoprotein recept ...... evere gram-negative infections

@ast

Low-density lipoprotein recept ...... evere gram-negative infections

@en

Low-density lipoprotein recept ...... evere gram-negative infections

@nl

prefLabel

Low-density lipoprotein recept ...... evere gram-negative infections

@ast

Low-density lipoprotein recept ...... evere gram-negative infections

@en

Low-density lipoprotein recept ...... evere gram-negative infections

@nl

P1433

Q24562428-E85239BE-F33A-4898-BB75-07F4F0A50858

P1476

Q24562428-0998A23B-C163-4089-9833-A7906CA29D66

P2093

Q24562428-10E242C5-8C72-43E6-B483-E58CA8BD65CE

Q24562428-3E2524B9-411D-450D-B89C-7AD09A0838C0

Q24562428-55907A80-11CC-483C-92D1-C24923DBF072

Q24562428-8D48AC96-42D1-4F0D-9B5D-4FE7B5A2B3BF

Q24562428-AEA4F8F6-2EF3-44A8-92D8-0EEEFDE12FAA

Q24562428-C8079595-1DF6-46CB-855A-648D2C70FCDC

Q24562428-E234D966-9B49-487B-A339-5B75905C840D

P2860

Q24562428-0C4665AA-FD29-4224-A8D1-4B5E15CCE839

Q24562428-12FD9335-6CB9-47D7-9789-451FC250B560

Q24562428-167F517C-C7B1-4447-8402-F2C7E859F3B3

Q24562428-19EAD93A-539C-40ED-9D58-DB1089295E6C

Q24562428-1CB268A9-AD18-4EA9-8DA2-FFF8C571C010

Q24562428-29900AB6-A961-42A9-AC76-04B723301E58

Q24562428-2C3A64E9-27B1-487A-AA00-D4A0A9BFEFDA

Q24562428-42946366-CE6C-4CE3-ACBA-8E2C4D6BA69F

Q24562428-5875E4C6-A830-4369-B1EA-7ABDF9BB8AA8

Q24562428-5A49493E-A662-4476-96ED-AD56B8BFB2B2

P304

Q24562428-E35766E2-2883-4098-BE96-597B584AB1FC

P31

Q24562428-669C8C52-E977-4FF8-A002-2BC486F89D43

P3181

Q24562428-24E58032-616A-4881-8611-6D5CE309BACC

P356

Q24562428-C70464C6-1269-4C76-A608-B9B6B8293ECE

P407

Q24562428-B6C3B3AE-5FC4-45AE-AE9A-158665CB57AB

P433

Q24562428-3EECB1A3-A086-41DC-8278-E933E8F791CA

P478

Q24562428-721020BD-5EDC-4ABC-A038-20DE26C4F7B5

P577

Q24562428-4815DDD9-1B9D-41E7-B981-51644464E3B1

P698

Q24562428-79CEEE62-ED6F-4ABB-8FA8-B40CEBBE48CE

P921

Q24562428-761E66C1-D9DF-4A2F-AA60-61FCF34F3436

Q24562428-88EE6571-F06D-4F33-B1DA-7EA105D732BD

P932

Q24562428-8EF53244-493A-4704-8DD0-CBF257510177

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Low-density lipoprotein recept ...... evere gram-negative infections

@en

P2093

A F Stalenhoef

http://www.w3.org/2001/XMLSchema#string

B J Kullberg

http://www.w3.org/2001/XMLSchema#string

I Verschueren

http://www.w3.org/2001/XMLSchema#string

J W van der Meer

http://www.w3.org/2001/XMLSchema#string

M G Netea

http://www.w3.org/2001/XMLSchema#string

O C Boerman

http://www.w3.org/2001/XMLSchema#string

P N Demacker

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection

Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice

The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

P304

1366-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2759503

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI118556

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

1996-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8617867

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

P932

507194

http://www.w3.org/2001/XMLSchema#string